Aligos Therapeutics Inc (ALGS-Q) Analyst Research & Price Targets - The Globe and Mail

Add to Watchlist Create Alerts

Real-Time Last Update

Last Sale Cboe BZX Real-Time

Volume

Current Target Price

High Target Price

Mean Target Price

Low Target Price

Median Target Price

Earnings Estimates

	Current Qtr06/2024	Next Qtr09/2024	Fiscal Yr12/2024	Fiscal Yr12/2025
Average Estimate	-0.16	-0.17	-0.74	-0.63
Number of Estimates	2	2	2	2
High Estimate	-0.16	-0.17	-0.73	-0.55
Low Estimate	-0.16	-0.17	-0.75	-0.71
Prior Year	-0.43	-0.41	-1.36	-0.74
Growth Rate Est. (year over year)	+62.79%	+58.54%	+45.59%	+14.86%

Earnings History - Surprises*

	Qtr Ending03/2024	Qtr Ending12/2023	Qtr Ending09/2023	Qtr Ending06/2023
Reported	$-0.22	$-0.22	$-0.41	$-0.43
Estimate	$-0.19	$-0.27	$-0.48	$-0.50
Difference	-0.03	+0.05	+0.07	+0.07
Surprise	-15.79%	+18.52%	+14.58%	+14.00%

* Earnings are based on GAAP income from continuing operations.

Average Analyst Ratings

4.33

3 Mths Ago3

4.33

2 Mths Ago3

4.33

1 Mth Ago3

4.33

Current3

Ratings Values:

Strong Buy5

Moderate Buy4

Hold3

Moderate Sell2

Strong Sell1

Ratings Breakdown

	3 Mths Ago	2 Mths Ago	1 Mth Ago	Current
# of Analysts:	3	3	3	3
	2	2	2	2
Holds	1	1	1	1

Key:

Strong Buy

Moderate Buy

Hold

Moderate Sell

Strong Sell

More from The Globe

At the open: S&P 500, Nasdaq hit intraday record highs after inflation data

Chevron tops Tesla as most-shorted stock in April, says Hazeltree

The close: Nasdaq at record high after Fed chair’s comments but TSX dips for third day

The close: S&P 500, TSX slip as investors await inflation data; meme rally reignites

Shopify executive earned US$76-million in 2023, far outpacing CEO’s compensation

Advantage Energy director buys as stock rallies

The close: S&P 500 higher but TSX slips as traders await key U.S. inflation data

You’ve heard of dollar-cost averaging. How about trying dollar-cost selling?